NHTSA Report: Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users
About this document
- Layer
- attachment: a document a meeting packet links to
- Type as titled
- publication (kind from doc_type)
- File
- 3a0160e9792366039c4c24908c2d7e1cb47c0353 application/pdf
- Cases
About: Jaime Bermudez (case)
Executive Summary
Background and Objective
Over the last few decades, there has been increased interest in how drugs other than alcohol may be affecting roadway safety due to several factors. First, in the United States the topic has gained prominence as an increasing number of States have legalized some form of cannabis consumption. Second, the “opioid epidemic” has prompted concerns that this class of drugs may be affecting drivers and other roadway users given large increases in use among the general public. Third, there are indications that prescription drug use is increasing. It is not fully understood how these changes may be affecting safety on America’s roads. Determining whether these factors and others have translated to more drugged driving has required an expanded research focus that includes consideration of drugs other than alcohol.
The National Highway Traffic Safety Administration began testing for drugs other than alcohol as part of its 2007 National Roadside Survey (NRS). In 2013 and 2014 NHTSA conducted another roadside study to estimate the change in drug- and alcohol-positive drivers on the road before and after Washington State legalized recreational use of cannabis. Such roadside studies provide an objective measure of the extent of alcohol and other drugs in drivers’ systems while they are actually on the roadway, but these studies do not include drivers involved in crashes. In 2010 and 2011 NHTSA sponsored the first large-scale and carefully controlled study in the United States designed to estimate the relative crash risk associated with drug use other than alcohol. While the study did include injury and fatal crashes, a large percentage (66.4%) of the sample consisted of drivers involved in property-damage-only crashes. Also, the study did not include information on drug prevalence among other roadway users such as pedestrians, bicyclists, and passengers involved in crashes.
While these studies have provided substantial insights into drugged driving, a knowledge gap exists regarding alcohol and other drug prevalence among drivers and other road users — pedestrians, bicyclists — who are seriously or fatally injured in crashes in the United States. The current study sought to fill the gaps in research by examining alcohol and other drug prevalence among a large sample of seriously injured drivers and other crash victims presenting to seven selected trauma centers and fatally injured crash victims presenting directly to four medical examiners (MEs). The drugs of interest were those known or suspected to impair cognitive and motor skills important for driving safely.
Methods
The study selected seven Level 1 trauma centers that served large catchment areas. Level 1 trauma centers care for people with traumatic injuries, such as from motor vehicle crashes. Participants (“seriously injured”) were included in the study if the facility alerted its trauma team. MEs were able to join the study at four of these sites. Specimen collection began on a rolling basis as shown below.
- • Jacksonville, FL – September 10, 2019 to July 31, 2021
- • Charlotte, NC – September 16, 2019 to July 31, 2021
- • Miami, FL – October 17, 2019 to July 31, 2021
- • Baltimore, MD – December 11, 2019 to July 31, 2021
- • Worcester, MA – January 27, 2020 to July 31, 2021
1
Keys: ← → or j k turn pages; / finds.